ArticleFrontiers in digital health2025
Multimodal learning for scalable representation of high-dimensional medical data.
Article in Frontiers in digital health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Integrating artificial intelligence (AI) with healthcare data is rapidly transforming medical diagnostics and driving progress toward precision medicine. However, effectively leveraging multimodal data, particularly digital pathology whole slide images (WSIs) and genomic sequencing, remains a significant challenge due to the intrinsic heterogeneity of these modalities and the need for scalable and interpretable frameworks. Existing diagnostic models typically operate on unimodal data, overlooking critical cross-modal interactions that can yield richer clinical insights. We introduce MarbliX (Multimodal Association and Retrieval with Binary Latent Indexed matriX), a self-supervised framework that learns to embed WSIs and immunogenomic profiles into compact, scalable binary codes, termed "monogram." By optimizing a triplet contrastive objective across modalities, MarbliX captures high-resolution patient similarity in a unified latent space, enabling efficient retrieval of clinically relevant cases and facilitating case-based reasoning. In lung cancer, MarbliX achieves 85%-89% across all evaluation metrics, outperforming histopathology (69%-71%) and immunogenomics (73%-76%). In kidney cancer, real-valued monograms yield the strongest performance (F1: 80%-83%, Accuracy: 87%-90%), with binary monograms slightly lower (F1: 78%-82%).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.